SEARCH

SEARCH BY CITATION

References

  • 1
    Jose P.J., Griffiths-johnson D.A., Collins P.D., et al. (1994) Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 179, 881.
  • 2
    Kameyoshi Y., Dorschner A., Mallet A.I., Christophers E., Schroder J.M. (1992) Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 176, 587.
  • 3
    Baggiolini M. & Dahinden C.A. (1994) CC chemokines in allergic inflammation. Immunol Today 15, 127.
  • 4
    Holgate S.T., Bodey K.S., Janezic A., Frew A.J., Kaplan A.P., Teran L.M. (1997) Release of RANTES, MIP-1α, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Resp Crit Care Med 156, 1377.
  • 5
    Rajakulasingam K., Hamid Q., O’Brien F., et al. (1997) RANTES in human allergen-induced rhinitis: cellular source and relation to tissue eosinophilia. Am J Resp Crit Care Med 155, 696.
  • 6
    Ying S., Meng Q., Taborda-barata L., et al. (1996) Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Eur J Immunol 26, 70.
  • 7
    Lim K.G., Wan H.C., Bozza P.T., et al. (1996) Human eosinophils elaborate the lymphocyte chemoattractants: IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol 156, 2566.
  • 8
    Lacy P., Mahmudi-azer S., Bablitz B., et al. (1999) Rapid mobilization of intracellularly stored RANTES in response to interferon-γ in human eosinophils. Blood 94, 23.
  • 9
    Lacy P., Levi-schaffer F., Mahmudi-azer S., et al. (1998) Intracellular localization of interleukin-6 in eosinophils from atopic asthmatics and effects of interferon γ. Blood 91, 2508.
  • 10
    Levi-schaffer F., Lacy P., Severs N.J., et al. (1995) Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood 85, 2579.
  • 11
    Hansel T.T., De Vries I.J., Iff T., et al. (1991) An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 145, 105.
  • 12
    Winqvist I., Olofsson T., Olsson I. (1984) Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein. Immunology 51, 1.
  • 13
    Fischer E., Capron M., Prin L., Kusnierz J.P., Kazatchkine M.D. (1986) Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3. Cell Immunol 97, 297.
  • 14
    Walls A.F., He S., Teran L.M., et al. (1995) Granulocyte recruitment by human mast cell tryptase. Int Arch Allergy Immunol 107, 372.
  • 15
    Moqbel R., Lacy P., Hagen S.C., Befus D. (1998) Mast cell tryptase-mediated granule protein release from human eosinophils. FASEB J 12, A592(Abs. #3435).
  • 16
    Valerius T., Repp R., Kalden J.R., Platzer E. (1990) Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action. J Immunol 145, 2950.
  • 17
    Hartnell A., Kay A.B., Wardlaw A.J. (1992) IFN-γ induces expression of FcγRIII (CD16) on human eosinophils. J Immunol 148, 1471.
  • 18
    Hartnell A., Robinson D.S., Kay A.B., Wardlaw A.J. (1993) CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 80, 281.
  • 19
    Fujisawa T., Fukuda S., Atsuta J., Ichimi R., Kamiya H., Sakurai M. (1994) Interferon-γ induces interleukin-3 release from peripheral blood eosinophils. Int Arch Allergy Immunol 104(Suppl. 1), 41.
  • 20
    Grewe M., Czech W., Morita A., et al. (1998) Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol 161, 415.
  • 21
    Moqbel R., Hamid Q., Ying S., et al. (1991) Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med 174, 749.
  • 22
    Ishihara C., Ochiai K., Kagami M., et al. (1997) Human peripheral eosinophils express functional interferon-γ receptors (IFN-γR). Clin Exp Immunol 110, 524.
  • 23
    Bruijnzeel P.L., Kok P.T., Hamelink M.L., Kijne A.M., Verhagen J. (1985) Exclusive leukotriene C4 synthesis by purified human eosinophils induced by opsonized zymosan. FEBS Lett 189, 350.
  • 24
    Fujisawa T., Abu-ghazaleh R., Kita H., Sanderson C.J., Gleich G.J. (1990) Regulatory effect of cytokines on eosinophil degranulation. J Immunol 144, 642.
  • 25
    Horie S., Gleich G.J., Kita H. (1996) Cytokines directly induce degranulation and superoxide production from human eosinophils. J Allergy Clin Immunol 98, 371.
  • 26
    Brach M.A., Sott C., Kiehntopf M., Herrmann F. (1994) Expression of the transforming growth factor-α gene by human eosinophils is regulated by interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor. Eur J Immunol 24, 646.
  • 27
    Elovic A.E., Ohyama H., Sauty A., et al. (1998) IL-4-dependent regulation of TGF-α and TGF-β1 expression in human eosinophils. J Immunol 160, 6121.
  • 28
    Wang P., Wu P., Cheewatrakoolpong B., Myers J.G., Egan R.W., Billah M.M. (1998) Selective inhibition of IL-5 receptor α-chain gene transcription by IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor in human blood eosinophils. J Immunol 160, 4427.
  • 29
    Marfaing-koka A., Devergne O., Gorgone G., et al. (1995) Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13. J Immunol 154, 1870.
  • 30
    Maune S., Berner I., Sticherling M., Kulke R., Bartels J., Schroder J.M. (1996) Fibroblasts but not epithelial cells obtained from human nasal mucosa produce the chemokine RANTES. Rhinology 34, 210.
  • 31
    Meyer J.E., Berner I., Teran L.M., et al. (1998) RANTES production by cytokine-stimulated nasal fibroblasts: its inhibition by glucocorticoids. Int Arch Allergy Immunol 117, 60.
  • 32
    Hariharan D., Douglas S.D., Lee B., Lai J.P., Campbell D.E., Ho W.Z. (1999) Interferon-γ upregulates CCR5 expression in cord and adult blood mononuclear phagocytes. Blood 93, 1137.
  • 33
    John M., Hirst S.J., Jose P.J., et al. (1997) Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J Immunol 158, 1841.
  • 34
    Stellato C., Beck L.A., Gorgone G.A., et al. (1995) Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol 155, 410.
  • 35
    Saito H., Hayakawa T., Mita H., Yui Y.S., Shida T. (1988) Augmentation of leukotriene C4 production by gamma interferon in leukocytes challenged with an allergen. Int Arch Allergy Appl Immunol 87, 286.
  • 36
    Corrigan C.J. & Kay A.B. (1990) CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Resp Dis 141, 970.
  • 37
    Cembrzynska-nowak M., Szklarz E., Inglot A.D., Teodorczyk-injeyan J.A. (1993) Elevated release of tumor necrosis factor-α and interferon-γ by bronchoalveolar leukocytes from patients with bronchial asthma. Am Rev Resp Dis 147, 291.
  • 38
    Kleinjanuary A., Dijkstra M.D., Boks S.S., Severijnen L.A., Mulder P.G., Fokkens W.J. (1999) Increase in IL-8, IL-10,IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation. J Allergy Clin Immunol 103, 441.
  • 39
    Krug N., Madden J., Redington A.E., et al. (1996) T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Resp Cell Mol Biol 14, 319.
  • 40
    Hansen G., Berry G., Dekruyff R.H., Umetsu D.T. (1999) Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 103, 175.
  • 41
    Holtzman M.J., Sampath D., Castro M., Look D.C., Jayaraman S. (1996) The one-two of T helper cells: does interferon-γ knock out the Th2 hypothesis for asthma? Am J Resp Cell Mol Biol 14, 316.
  • 42
    Sim T.C., Reece L.M., Hilsmeier K.A., Grant J.A., Alam R. (1995) Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Resp Crit Care Med 152, 927.
  • 43
    Weido A.J., Reece L.M., Alam R., Cook C.K., Sim T.C. (1996) Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen- induced rhinitis. Ann Allergy Asthma Immunol 77, 407.